Skip to main content
. Author manuscript; available in PMC: 2020 Nov 29.
Published in final edited form as: J Proteome Res. 2020 Jan 27;19(2):794–804. doi: 10.1021/acs.jproteome.9b00641

Figure 6: Prediction of the potential prognostic marker and their association with patient survival.

Figure 6:

The differentially expressed proteins (DEPs) identified from MiaPaCa (shMYB vs. Scr) and BxPC3 (MYB vs. Neo) were subjected to biomarker comparison using IPA. (A) 57 proteins with potential biomarker properties were identified common to both the subsets. (B) Gene expression of 4 DEPs between pancreas and pancreatic carcinoma was determined using the Oncomine database. (C) Association of expression with survival of pancreatic cancer patients was identified from the TCGA database using UALCAN. (D) Immunohistochemistry data of the selected protein in pancreas and pancreatic cancer was obtained from Human Protein Atlas. Data for INHBA was being curated at this time.